BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03725059-completion@plaintrial.com
DTSTAMP:20261028T214100Z
DTSTART;VALUE=DATE:20310124
SUMMARY:Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With
  Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of
  Early-Stage Estrogen Receptor-Positive\, Human Epidermal Growth Factor Re
 ceptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) — 
 estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03725059
URL:https://plaintrial.com/trial/NCT03725059
END:VEVENT
END:VCALENDAR